Evidence map›Paper›PMID 27411719›Full record

ArticleBMC complementary and alternative medicine2016

Chondroprotective and anti-inflammatory effects of ChondroT, a new complex herbal medication.

Jung Up Park, Seon-Jong Kim, Chang-Su Na, Chan-Hun Choi, Chang Seob Seo, Jong-Keun Son, Bok Yun Kang, Young Ran Kim

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Molecules (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jung Up ParkCollege of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju, 500-757, Republic of Korea.
Seon-Jong KimCollege of Korean Medicine, Dongshin University, Naju-si, 58245, Republic of Korea.
Chang-Su NaCollege of Korean Medicine, Dongshin University, Naju-si, 58245, Republic of Korea.
Chan-Hun ChoiCollege of Korean Medicine, Dongshin University, Naju-si, 58245, Republic of Korea.
Chang Seob SeoKorea Institute of Oriental Medicine, Daejeon, 34054, Republic of Korea.
Jong-Keun SonCollege of Pharmacy, Yeungnam University, Gyeongsan-si, Republic of Korea.
Bok Yun KangCollege of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju, 500-757, Republic of Korea.
Young Ran KimCollege of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju, 500-757, Republic of Korea. kimyr@chonnam.ac.kr.
Chonnam National University · KRDongshin University · KRKorea Institute of Oriental Medicine · KRYeungnam University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGanghwaljetongyeum (GHJTY) is a complex herbal decoction comprising 18 plants; it is used to treat arthritis. In order to develop a new anti-arthritic herbal medication, we selected 5 out of 18 GHJTY plants by using bioinformatics analysis. The new medication, called ChondroT, comprised water extracts of Osterici Radix, Lonicerae Folium, Angelicae Gigantis Radix, Clematidis Radix, and Phellodendri Cortex. This study was designed to investigate its chondroprotective and anti-inflammatory effects to develop an anti-arthritic herb medicine.

methodsChondroT was validated using a convenient and accurate high-performance liquid chromatography-photodiode array (HPLC-PDA) detection method for simultaneous determination of its seven reference components. The concentrations of the seven marker constituents were in the range of 0.81-5.46 mg/g. The chondroprotective effects were evaluated based on SW1353 chondrocytes and matrix metalloproteinase 1 (MMP1) expression. In addition, the anti-inflammatory effects of ChondroT were studied by Western blotting of pro-inflammatory enzymes and by enzyme-linked immunosorbent assay (ELISA) of inflammatory mediators in lipopolysaccharides (LPS)-induced RAW264.7 cells.

resultsChondroT enhanced the growth of SW1353 chondrocytes and also significantly inhibited IL-1β-induced MMP-1 expression. However, ChondroT did not show any effects on the growth of HeLa and RAW264.7 cells. The expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) was induced by LPS in RAW264.7 cells, which was significantly decreased by pre-treatment with ChondroT. In addition, ChondroT reduced the activation of NF-kB and production of inflammatory mediators, such as IL-1β, IL-6, PGE2, and nitric oxide (NO) in LPS-induced RAW264.7 cells.

conclusionsThese results show that ChondroT exerted a chondroprotective effect and demonstrated multi-target mechanisms related to inflammation and arthritis. In addition, the suppressive effect was greater than that exhibited by GHJTY, suggesting that ChondroT, a new complex herbal medication, has therapeutic potential for the treatment of arthritis.

Indexed as

AnimalsAnti-Inflammatory AgentsBiomarkersCell ProliferationChondrocytesCytokinesMiceOxidative StressPlant PreparationsProtective AgentsRAW 264.7 CellsReproducibility of ResultsAnti-Inflammatory AgentsBiomarkersCytokinesPlant PreparationsProtective AgentsAnti-arthritic drugChondrocyteChondroTCOX-2Inflammatory cytokinesiNOSMMP-1

Identifiers

PMID27411719
PMCPMC4944440
OpenAlexW2460101305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.